BVS

NASD Bioventus, Inc. Class A

Nov 4, 2026 · 9:56 PM ET EOD Market Closed

$11.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.42, $0.51 below the day’s high of $11.93

YTD change: +53.49%
vs 20-day SMA: -16.64%
vs 200-day SMA: +4.37%

Price ranges

Previous day

$10.09 $11.36

open $10.98 close $10.95

-$0.04 (-0.32%)

Today

$11.17 $11.93

open $11.24 now $11.42

+$0.18 (+1.60%)

Past week

$10.09 $15.09

from $14.42 now $11.42

-$3.00 (-20.80%)

Past month

$10.09 $15.33

from $13.10 now $11.42

-$1.68 (-12.82%)

This year

$7.14 $15.89

from $7.44 now $11.42

+$3.98 (+53.49%)

Price & Performance

+1.25 (+12.29%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 42.7% away from all-time highs of $19.94
BVS is up 53% since the beginning of the year
BVS is up 51% over the past 12 months
BVS is down 13% over the past 1 month
9% of all BVS investors are betting against BVS

BVS reads neutral: price sits above one of the two key moving averages, the 12-month move is +51.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.17

Earnings momentum +1.3% Quarterly EPS growth

Quarterly change +1.3%

Valuation

P/E ratio 17.08

Enterprise value $1.1B

Beta 0.88

Balance sheet & scale

Income$57.3K

Revenue$585.6M

Cash$30.7M

Debt$244.2K

Income / Debt 0.23×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $962.2M

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Competitor comparison

Ticker	Company	Price	Change
JNJ.CAT	JOHNSON & JOHNSON CIBC CDR C REG S	$35.20	+3.96%
BDX	Becton, Dickinson and Company	$209.19	+5.56%
MDLN	Medline, Inc. Class A	$40.35	+18.36%
DXCM	DexCom, Inc.	$88.48	+6.64%
WST	West Pharmaceutical Services, Inc.	$408.78	+0.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.